ReFocus Eye Health, a collaborative healthcare organization, announced that it has acquired Soll Eye. The acquisition, effective immediately, brings all four Soll Eye locations across Pennsylvania and New Jersey to the Refocus Eye Health family, as well as Soll Eye’s team of doctors and staff.
Terms of the deal were not disclosed.
“I am thrilled to share the news that Soll Eye has partnered with ReFocus,” Dr. Stephen Soll, Founder of Soll Eye, said in a company news release. “My team and I will have greater access to cutting-edge technology and other resources to better serve our patients and community at all Soll Eye locations.”
With more than 60 years of serving patients, Soll Eye is one of the top eye health providers in the Northeast. Its team of seven doctors deliver a spectrum of vision services ranging from primary eye care, cataract surgery, vitreo-retinal procedures and other treatments.
“Providing the strategy, innovation, and support to bring better eye care to people is our primary goal at ReFocus,” Dan Doman, CEO of ReFocus Eye Health, said in the news release. “Our acquisition of Soll Eye helps us further build on this mission, while lending the power of our expertise and resources to the talented doctors and team at its locations.”
“This partnership establishes an important foothold for ReFocus in the Pennsylvania and New Jersey markets,” added Sean Hayes, Partner at Zenyth Partners. “We look forward to working with Dr. Soll and his team to extend our footprint while continuing to deliver exceptional eye care to our patients.”